20 days ago
RYTM
AnalystsJeffrey HungJeffrey Hung's Stock Forecasts
AnalystsJeffrey Hung
Sectors:
Analyst Ranking
Top 16%
#781 out of 4995 analysts
Average Return
+6.59%
Win Rate
55%63 out of 114
Risk vs Reward
Poor
Good
Jeffrey Hung's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Myokardia IncMYOK | +314.95% | $53.26 | $221.00 | 2020-04-15 - 2020-10-06 | Strong Buy |
Cytokinetics IncCYTK | +182.40% | $33.19 | $93.73 | 2023-08-04 - 2024-01-05 | Strong Buy |
Cytokinetics IncCYTK | +151.83% | $37.22 | $93.73 | 2023-06-22 - 2024-01-05 | Strong Buy |
Contineum Therapeutics IncCTNM | +127.46% | $4.37 | $9.94 | 2025-05-19 - 2025-08-22 | Strong Buy |
Disc Medicine IncIRON | +108.90% | $28.10 | $58.70 | 2023-04-20 - 2023-12-19 | Strong Buy |
Jeffrey Hung Analyst Color
Get additional color on Jeffrey Hung's coverage of popular stocks
a month ago
NBIX
a month ago
FOLD
2 months ago
CGON
6 months ago
PTCT
6 months ago
JAZZ
7 months ago
NBIX
8 months ago
PTCT
10 months ago
ITCI
a year ago
CNTA
a year ago
NBIX
2 years ago
RYTM
2 years ago
FOLD
2 years ago
BLUE
Jeffrey Hung's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ptc Therapeutics IncPTCT | 12 | Strong Buy | $71.00 | +40.40% | Maintains | 6 days ago |
Cullinan Therapeutics IncCGEM | 6 | Strong Buy | $28.00 | +241.88% | Maintains | 8 days ago |
Contineum Therapeutics IncCTNM | 4 | Strong Buy | $21.00 | +111.27% | Maintains | 8 days ago |
Erasca IncERAS | 4 | Hold | $2.00 | +25.00% | Downgrades | 8 days ago |
Bicycle Therapeutics PLCBCYC | 6 | Hold | $13.00 | +83.10% | Maintains | 14 days ago |
Rhythm Pharmaceuticals IncRYTM | 11 | Strong Buy | $109.00 | +5.55% | Maintains | 20 days ago |
Jazz Pharmaceuticals PLCJAZZ | 8 | Strong Buy | $162.00 | +31.59% | Maintains | 20 days ago |
Neurocrine Biosciences IncNBIX | 13 | Strong Buy | $158.00 | +16.67% | Maintains | a month ago |
Amicus Therapeutics IncFOLD | 5 | Strong Buy | $108.00 | +1,319.19% | Upgrades | a month ago |
Ultragenyx Pharmaceutical IncRARE | 8 | Strong Buy | $55.00 | +84.69% | Maintains | a month ago |
Cg Oncology IncCGON | 4 | Strong Buy | $56.00 | +108.06% | Maintains | 2 months ago |
Acadia Pharmaceuticals IncACAD | 20 | Hold | $24.00 | -6.76% | Maintains | 3 months ago |
Engene Holdings IncENGN | 3 | Strong Buy | $34.00 | +687.04% | Maintains | 6 months ago |
Disc Medicine IncIRON | 6 | Strong Buy | $85.00 | +40.85% | Assumes | 6 months ago |
Centessa Pharmaceuticals PLCCNTA | 2 | Strong Buy | $27.00 | +58.73% | Assumes | 6 months ago |
Bioage Labs IncBIOA | 2 | Strong Sell | $5.00 | +8.46% | Assumes | 6 months ago |
Cytokinetics IncCYTK | 7 | Strong Buy | $67.00 | +74.75% | Upgrades | 6 months ago |
Intra Cellular Therapies IncITCI | 5 | Strong Buy | $95.00 | -27.96% | Maintains | 10 months ago |
Cervomed IncCRVO | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | a year ago |
Crinetics Pharmaceuticals IncCRNX | 2 | Strong Buy | $70.00 | N/A | Maintains | a year ago |
Karuna Therapeutics IncKRTX | 3 | Hold | $330.00 | N/A | Downgrades | 2 years ago |
Prelude Therapeutics IncPRLD | 6 | Strong Sell | $4.00 | N/A | Downgrades | 2 years ago |
Vigil Neuroscience IncVIGL | 1 | Strong Sell | $4.00 | N/A | Downgrades | 2 years ago |
Invivyd IncIVVD | 1 | Hold | $4.00 | N/A | Upgrades | 2 years ago |
Bluebird Bio IncBLUE | 1 | Hold | $140.00 | N/A | Upgrades | 2 years ago |
Immuneering CorpIMRX | 3 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Esperion Therapeutics IncESPR | 7 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Repare Therapeutics IncRPTX | 5 | Hold | $14.00 | N/A | Maintains | 2 years ago |
Lenz Therapeutics IncLENZ | 4 | Hold | $3.00 | N/A | Maintains | 3 years ago |
Cyteir Therapeutics IncCYTT | 3 | Strong Sell | $2.00 | N/A | Downgrades | 3 years ago |
Celularity IncCELU | 3 | Strong Sell | $10.00 | N/A | Downgrades | 3 years ago |
Cincor Pharma IncCINC | 6 | Hold | $30.00 | N/A | Maintains | 3 years ago |
Exelixis IncEXEL | 2 | Hold | $22.00 | N/A | Maintains | 3 years ago |
Rubius Therapeutics IncRUBY | 3 | Hold | $1.50 | N/A | Maintains | 3 years ago |
Evofem Biosciences IncEVFM | 6 | Strong Sell | $0.75 | N/A | Maintains | 3 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $146.00 | N/A | Maintains | 3 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $180.00 | N/A | Downgrades | 4 years ago |
Aprea Therapeutics IncAPRE | 5 | Strong Sell | $60.00 | N/A | Downgrades | 4 years ago |
Voyager Therapeutics IncVYGR | 2 | Hold | $7.00 | N/A | Maintains | 5 years ago |
Myokardia IncMYOK | 2 | Hold | $225.00 | N/A | Downgrades | 5 years ago |
Nextcure IncNXTC | 6 | Strong Buy | $648.00 | N/A | Maintains | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.